Biopharmaceuticals have arrived in a big way in the Indian pharmaceuticals industry. The existing market has merely scratched the surface of the hidden treasures that will be completely revealed one i
August 21, 2006 (Press Release) --
The Indian pharmaceutical industry has seen a new spate of opportunities with the expansion of market for Biopharmaceutical products. This segment comprises of those medical drugs, which are produced through the application of ‘biotechnology’. This emerging field of bioscience has generated enough excitement in the World Pharmaceutical Industry, since 1982 when recombinant insulin, was first approved for therapeutic use.
Even though the biopharma sector is still in its infancy, its share of $800 million in the $1,065 million pharmaceuticals market in India is considerably large. Currently, There are about 35 major players in the Indian Biopharmaceuticals sector.
Since January 2005 with the implementation of the Product-patent system, the sector is witnessing a swing towards innovation-based research; a volte-face from the ongoing generics based R&D. pharmaceuticals sector in India is up for major inputs for producing a better range of products especially recombinant therapeutics.
The market research report,” Opportunities in Indian Pharma Sector”, by RNCOS ascertains that in the period 2004-05, biopharmaceuticals segment comprising of therapeutics, vaccines, and diagnostics, represented 75 % of the market share.
Analysts opine that Biopharmaceutical market is poised for growth with cost cutting and aggressive pricing strategy. Opportunities in Indian pharma sector are on the rise with Indian drug companies achieving a competitive nature.
The report seeks answers to the major industry specific questions, such as:
• What are the emerging trends in the Pharmaceuticals sector in India?
• What are the key regulations and the policy environment in the industry?
• What is the future scenario of the Pharmaceuticals market in India?
• Who are the Key players in the Pharmaceutical Market in India?
• What are the opportunities and threats in the pharmaceuticals sector in India?
• How competitive is the Indian pharmaceuticals market vis-à-vis the World Pharmaceutical Industry?
This research report on pharma sector gives a comprehensive view of the industry with emphasis on the Indian Biopharmaceuticals sector.
About RNCOS:
RNCOS, incorporated in 2002, provides Market Research Reports for your business needs and aims to put an end to your information pursuit. Our expertise in gathering global business information for industry research, corporate training, growth consulting, and business consulting, brings reputed companies and firms to us for business enhancement solutions. We can be your one-stop-shop for Industry research information and niche market analysis.
To purchase your copy: http://www.rncos.com/Report/IM055.htm
For more information about the report please visit www.rncos.com
Even though the biopharma sector is still in its infancy, its share of $800 million in the $1,065 million pharmaceuticals market in India is considerably large. Currently, There are about 35 major players in the Indian Biopharmaceuticals sector.
Since January 2005 with the implementation of the Product-patent system, the sector is witnessing a swing towards innovation-based research; a volte-face from the ongoing generics based R&D. pharmaceuticals sector in India is up for major inputs for producing a better range of products especially recombinant therapeutics.
The market research report,” Opportunities in Indian Pharma Sector”, by RNCOS ascertains that in the period 2004-05, biopharmaceuticals segment comprising of therapeutics, vaccines, and diagnostics, represented 75 % of the market share.
Analysts opine that Biopharmaceutical market is poised for growth with cost cutting and aggressive pricing strategy. Opportunities in Indian pharma sector are on the rise with Indian drug companies achieving a competitive nature.
The report seeks answers to the major industry specific questions, such as:
• What are the emerging trends in the Pharmaceuticals sector in India?
• What are the key regulations and the policy environment in the industry?
• What is the future scenario of the Pharmaceuticals market in India?
• Who are the Key players in the Pharmaceutical Market in India?
• What are the opportunities and threats in the pharmaceuticals sector in India?
• How competitive is the Indian pharmaceuticals market vis-à-vis the World Pharmaceutical Industry?
This research report on pharma sector gives a comprehensive view of the industry with emphasis on the Indian Biopharmaceuticals sector.
About RNCOS:
RNCOS, incorporated in 2002, provides Market Research Reports for your business needs and aims to put an end to your information pursuit. Our expertise in gathering global business information for industry research, corporate training, growth consulting, and business consulting, brings reputed companies and firms to us for business enhancement solutions. We can be your one-stop-shop for Industry research information and niche market analysis.
To purchase your copy: http://www.rncos.com/Report/IM055.htm
For more information about the report please visit www.rncos.com
Email
Print
SPAM
